Chemically induced parkinson's disease II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 158 (1) , 63-71
- https://doi.org/10.1016/s0006-291x(89)80177-9
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Chemically induced Parkinson's disease: Intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ionBiochemical and Biophysical Research Communications, 1987
- Interactions of the 1-methyl-4-phenyl-2, 3-dihydropyridinium species with synthetic dopamine-melaninLife Sciences, 1986
- The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metalsBiochemical and Biophysical Research Communications, 1985
- High-affinity binding sites for [3H]MPTP may correspond to monamine oxidaseEuropean Journal of Pharmacology, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Melanin Affinity of 1‐Methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine, an Inducer of Chronic Parkinsonism in HumansActa Pharmacologica et Toxicologica, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Triplet states of copper and metal-free phthalocyaninesJournal of the Chemical Society, Faraday Transactions 2: Molecular and Chemical Physics, 1978
- Pulse radiolysis apparatusJournal of Scientific Instruments, 1964